Today is World Diabetes Day. Stakeholders are concerned by the growing number of people with diabetes who cannot access the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The Flagship Initiative to Accelerate Cell Therapies, An Anticipated Pathway to Cures for Type 1 Diabetes, Is Made Possible by Initial Transformational Gifts Totaling $75 Million Project ACT will be ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Since its initial public offering, Convatec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy business. By and large, we like Convatec’s ...

The many benefits of jogging extend to your body, brain, and overall well-being. Jogging aids heart health and weight loss, ...

But in the back of my head — where lurks the constant accounting about the cost of diabetes — I was worried about what we ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...